Sekar Kathiresan

1 ta ish

Verve Therapeutics (United States)

1. New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing

   Reindert F. Oostveen, Amit V. Khera, Sekar Kathiresan +5

   Sharh maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.057849